Supplementary tables and figures Supplementary Table 1 Type of anti-psychotic medication just before entering the initial acute oral treatment phase Paliperidone Oral antipsychotics Total number of ATC Term/Preferred Term palmitate (n=352) (n=363) subjects (n=715) Number of subjects with at least one antipsychotic medication just before 217 (61.6) 221 (60.9) 438 (61.3) entering the initial acute oral treatment phase Benzamides 15 (4.3) 15 (4.1) 30 (4.2) Amisulpride 15 (4.3) 13 (3.6) 28 (3.9) Tiapride 0 2 (0.6) 2 (0.3) Butyrophenone derivatives 43 (12.2) 42 (11.6) 85 (11.9) Haloperidol 43 (12.2) 42 (11.6) 85 (11.9) Diazepines, oxazepines, thiazepines and oxepines 55 (15.6) 49 (13.5) 104 (14.5) Clozapine 0 1 (0.3) 1 (0.1) Loxapine 3 (0.9) 1 (0.3) 4 (0.6) Olanzapine 36 (10.2) 21 (5.8) 57 (8.0) Quetiapine 8 (2.3) 16 (4.4) 24 (3.4) Quetiapine fumarate 11 (3.1) 10 (2.8) 21 (2.9) Indole derivatives 4 (1.1) 8 (2.2) 12 (1.7)
Supplementary tables and figures Supplementary Table 1 Type of anti-psychotic medication just before entering the initial acute oral treatment phase ATC Term/Preferred Term Paliperidone palmitate (n=352) Oral antipsychotics (n=363) Total number of subjects (n=715) Number of subjects with at least one antipsychotic medication just before entering the initial acute oral treatment phase 217 (61.6) 221 (60.9) 438 (61.3) Benzamides 15 (4.3) 15 (4.1) 30 (4.2) Amisulpride 15 (4.3) 13 (3.6) 28 (3.9) Tiapride 0 2 (0.6) 2 (0.3) Butyrophenone derivatives 43 (12.2) 42 (11.6) 85 (11.9) Haloperidol 43 (12.2) 42 (11.6) 85 (11.9) Diazepines, oxazepines, thiazepines and oxepines 55 (15.6) 49 (13.5) 104 (14.5) Clozapine 0 1 (0.3) 1 (0.1) Loxapine 3 (0.9) 1 (0.3) 4 (0.6) Olanzapine 36 (10.2) 21 (5.8) 57 (8.0) Quetiapine 8 (2.3) 16 (4.4) 24 (3.4) Quetiapine fumarate 11 (3.1) 10 (2.8) 21 (2.9) Indole derivatives 4 (1.1) 8 (2.2) 12 (1.7)
1-s2.0-S0920996415004442-mmc1.docx